Brief: Cerus Corporation Announces FDA Approval For INTERCEPT Blood System for Cryoprecipitation
30/11/2020 13:36
Nov 30 (Reuters) - Cerus Corp CERS.O :
* CERUS CORPORATION ANNOUNCES FDA APPROVAL FOR INTERCEPT
BLOOD
SYSTEM FOR CRYOPRECIPITATION
Source text for Eikon: ID:nBwcfWHGBa
Further company coverage: CERS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cerus
See all newsCerus Corp reports results for the quarter ended June 30 - Earnings Summary
Cerus Q2 adjusted EBITDA misses estimates, raises 2026 outlook
Brief: Cerus Q2 Gross Profit USD 29.5 Million
Cerus Corp expected to post a loss of 1 cent a share - Earnings Preview
Brief: Cerus Corporation Closes New Debt Facility Of Up To $110 Million